AFT Pharmaceuticals Ltd.(NZ:AFT)
NZ$4.67+0.15 (+3.32%)
NZ:AFT
AFT Pharmaceuticals Ltd. financials statements
NZ$4.67
At close:+0.15 (+3.32%)
Want to see NZ:AFT full AI Analyst Report?
AFT Pharmaceuticals Ltd. (AFT) Financial Statements
AFT Pharmaceuticals Ltd. Financial Overview
AFT Pharmaceuticals Ltd.'s market cap is currently NZ$471.94M. The company's EPS TTM is NZ$0.14; its P/E ratio is 32.04; and it has a dividend yield of 0.65%. AFT Pharmaceuticals Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NZ$ 254.71M | NZ$ 205.49M | NZ$ 195.41M | NZ$ 155.82M | NZ$ 129.83M |
| Gross Profit | NZ$ 110.55M | NZ$ 89.19M | NZ$ 88.27M | NZ$ 72.16M | NZ$ 61.30M |
| Operating Income | NZ$ 24.86M | NZ$ 11.70M | NZ$ 24.23M | NZ$ 18.67M | NZ$ 20.08M |
| EBITDA | NZ$ 28.55M | NZ$ 21.52M | NZ$ 27.72M | NZ$ 20.40M | NZ$ 21.12M |
| Net Income | NZ$ 14.73M | NZ$ 11.96M | NZ$ 15.61M | NZ$ 10.65M | NZ$ 19.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NZ$ 10.24M | NZ$ 11.11M | NZ$ 12.04M | NZ$ 4.75M | NZ$ 7.94M |
| Total Assets | NZ$ 217.01M | NZ$ 169.81M | NZ$ 165.26M | NZ$ 148.06M | NZ$ 121.76M |
| Total Debt | NZ$ 54.11M | NZ$ 30.00M | NZ$ 32.19M | NZ$ 38.05M | NZ$ 40.51M |
| Net Debt | NZ$ 43.87M | NZ$ 18.89M | NZ$ 20.15M | NZ$ 33.30M | NZ$ 32.57M |
| Total Liabilities | NZ$ 107.94M | NZ$ 72.74M | NZ$ 77.46M | NZ$ 74.80M | NZ$ 65.02M |
| Stockholders' Equity | NZ$ 110.28M | NZ$ 97.64M | NZ$ 87.80M | NZ$ 73.27M | NZ$ 56.74M |
| Cash Flow | |||||
| Free Cash Flow | NZ$ -11.87M | NZ$ 6.22M | NZ$ 16.02M | NZ$ -173.00K | NZ$ 6.64M |
| Operating Cash Flow | NZ$ -11.75M | NZ$ 13.18M | NZ$ 25.55M | NZ$ 9.00M | NZ$ 12.22M |
| Investing Cash Flow | NZ$ -9.76M | NZ$ -6.95M | NZ$ -9.53M | NZ$ -9.18M | NZ$ -5.58M |
| Financing Cash Flow | NZ$ 11.01M | NZ$ -6.81M | NZ$ -10.63M | NZ$ -6.98M | NZ$ -3.91M |
Currency in NZD
